Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime?
Advances in Chronic Kidney Disease · 2019-03 · 26 (2) · 122-130
DOI: 10.1053/j.ackd.2019.03.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Chronic Kidney Disease, 2019-03. Verfasst von Ian R Barrows und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Georgetown University School of Medicine, Washington, DC; Division of Kidney Diseases and Hypertension, George Washington Uni…. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Georgetown University School of Medicine, Washington, DC; Division of Kidney Diseases and Hypertension, George Washington University School of Medicine, Washington, DC.
- Department of Medicine, Georgetown University School of Medicine, Washington, DC; Division of Kidney Diseases and Hypertension, George Washington University School of Medicine, Washington, DC. Electronic address: draj@m…
Förderung
- NIDDK NIH HHS
Zitieren
APA
Barrows, I. R., Ramezani, A., & Raj, D. S. (2019). Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime?. Advances in Chronic Kidney Disease, 26(2), 122-130. https://doi.org/10.1053/j.ackd.2019.03.001
Vancouver
Barrows IR, Ramezani A, Raj DS. Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime?. Advances in Chronic Kidney Disease. 2019;26(2):122-130. doi:10.1053/j.ackd.2019.03.001
BibTeX
@article{Barrows2019,
author = {Barrows, Ian R and Ramezani, Ali and Raj, Dominic S},
title = {Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime?},
journal = {Advances in Chronic Kidney Disease},
year = {2019},
volume = {26},
number = {2},
pages = {122--130},
doi = {10.1053/j.ackd.2019.03.001}
}
EUVIMED